Clinical Trial Update: Temozolomide as a Prophylaxis Against Brain Recurrence in Participants With Metastatic Breast Cancer (P05225 AM2) [Phase 2]

View source ↗

Summary

A Phase 2 study evaluated temozolomide as prophylaxis against brain recurrence in metastatic breast cancer; the trial (P05225 AM2) was terminated with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Breast Cancer

Drugs mentioned

• Temozolomide (Temozolomide)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Breast Neoplasm, Brain Neoplasm | Phase 2 | Status: TERMINATED | Results posted: 2011-07-22